NCT03362229

Brief Summary

Medial malleolus: Operative Or Non-operative (MOON study) Ankle fractures are a common Orthopaedic trauma presentation, accounting for approximately 10% of the workload. There has been debate regarding the significance of the contribution of the medial malleolus to ankle stability. Some deem the lateral malleolus as the key stabiliser. With this anatomically aligned the ankle joint should be stable. Operating on the medial malleolus fracture often requires a second generous skin incision, soft tissue stripping and insertion of metalwork. This carries with it the risk of wound complications, infection and increased operation time. High risk patients including the elderly, diabetics and those with significant swelling following injury are particularly vulnerable. The study will include adult patients (≥16 years) with capacity to consent and complete post-operative questionnaires, presenting to a single Orthopaedic trauma unit. Participants will be randomised to fixation or non-fixation of associated medial malleolus fractures at the same time as fixation of the lateral malleolar fracture to assess if this impacts on validated patient outcomes, failure, operative time and complications over a one-year follow-up. Only one trial has been published, showing no significant difference between failure rates or outcomes, but reduced operative time. Participants will be enrolled into the trial following informed consent. The final decision on whether a participant is eligible can only be made during surgery when the medial malleolus fracture has reduced with no more than 2mm displacement. If this is confirmed the participant will be randomised to receive either fixation or non-fixation of the medial malleolus. Randomisation therefore occurs at the time of surgery. Participants will be reviewed at set post-operative checkpoints, with X-rays and patient reported outcome scores. Trial data will hopefully enable surgeons to make better informed decisions when managing patients with ankle fracture dislocations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 24, 2017

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

November 9, 2017

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 5, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

August 26, 2021

Status Verified

August 1, 2021

Enrollment Period

3.8 years

First QC Date

November 9, 2017

Last Update Submit

August 25, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Olerud & Molander Ankle Score (OMAS) over a one-year post-operative period

    The OMAS is a functional rating scale developed in 1984, which has been used extensively as a research tool in foot and ankle surgery. It includes nine parameters: pain, stiffness, swelling, stair climbing, running, jumping, squatting, supports and work/activities of daily living. The sub-score parameters are summated to generate a final score from 0 - 100, with '100' representing an excellent functional outcome and '0' being the worse possible outcome.

    6 week, 3 months, 6 months and one year.

Secondary Outcomes (4)

  • Change in Euroqol-5D over a one-year post-operative period

    6 week, 3 months, 6 months and one year.

  • Change in Manchester-Oxford Foot Questionnaire (MOXFQ) over a one-year post-operative period

    6 week, 3 months, 6 months and one year.

  • Tourniquet time

    Immediately post-operatively

  • Change in Visual analogue pain scale (VAS) over a one-year post-operative period

    6 week, 3 months, 6 months and one year.

Study Arms (2)

FIXATION

ACTIVE COMPARATOR

Medial malleolus fixation, with the method of fixation left to the surgeons discretion.

Procedure: Fixation

NON-FIXATION

ACTIVE COMPARATOR

A well reduced medial malleolus fracture is then left without fixation ie, non-operative management.

Procedure: Non-fixation

Interventions

FixationPROCEDURE

A well reduced medial malleolus fracture will undergo internal fixation, guided by the surgeon's skill and expertise

FIXATION
Non-fixationPROCEDURE

A well reduced medial malleolus fracture will be left without fixation

NON-FIXATION

Eligibility Criteria

Age16 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsWe hypothesise we will recruit slightly more females than males as this is our experience in our local unit with routine practice.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥16 years
  • Able to consent to treatment
  • Unstable fracture dislocation of the ankle joint requiring operative intervention as defined in section 3.1
  • Closed injury
  • Weber B \& Weber C fractures
  • Surgery date within two weeks of date of fracture

You may not qualify if:

  • Patients unable to comply with post-operative data gathering including completing questionnaires in English language
  • Additional lower limb injury, which may impact on patient rehabilitation
  • Open fracture
  • Confirmed severe associated neurovascular injuries
  • Distal tibial intra-articular fractures/ pilon type injuries
  • Supination-adduction type 2 (SAD-2) fracture configurations with a medial malleolus vertical shear fracture
  • Patients medically unfit for surgery
  • Patients declining operative management
  • Non-residents, unable to return to the unit for follow-up for a period of 1-year
  • Current engagement in a pharmaceutical/drug trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Edinburgh Orthopaedic Trauma Unit, Edinburgh Royal Infirmary

Edinburgh, EH16 4SA, United Kingdom

Location

Related Publications (2)

  • Carter TH, Oliver WM, Bell KR, Graham C, Duckworth AD, White TO. Operative vs Nonoperative Management of Unstable Medial Malleolus Fractures: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jan 2;7(1):e2351308. doi: 10.1001/jamanetworkopen.2023.51308.

  • Carter TH, Oliver WM, Graham C, Duckworth AD, White TO. Medial malleolus: Operative Or Non-operative (MOON) trial protocol - a prospective randomised controlled trial of operative versus non-operative management of associated medial malleolus fractures in unstable fractures of the ankle. Trials. 2019 Sep 12;20(1):565. doi: 10.1186/s13063-019-3642-7.

MeSH Terms

Conditions

Ankle Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesAnkle InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
There is no blinding possible in this trial as the presence or absence of medial sided surgery is obvious to both the surgeon and the patient due to the presence or absence of a skin incision.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised controlled trial with 50:50 randomisation into one of 2 groups. Randomisation will also be stratified be age of patient (\>= 65 and \<65 years).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigagor

Study Record Dates

First Submitted

November 9, 2017

First Posted

December 5, 2017

Study Start

October 24, 2017

Primary Completion

August 1, 2021

Study Completion

August 1, 2021

Last Updated

August 26, 2021

Record last verified: 2021-08

Locations